400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2300073698
结束
/
/
/
2023-07-19
/
/
pilonidal sinus
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
The primary outcomes were duration of healing, post-operative morbidities, persistence of discharge and recurrence at 1-7 years (for cases enrolled in 2021 from 2015 respectively). The secondary outcomes were operative time, return to work, cosmetic results and patients satisfaction. Patients were observed for wound healing and discharge on follow up in OPD at 1, 3, 6 and 24 weeks. They were further followed up every year through telephonic survey for persistence or recurrence of symptoms. Patients satisfaction was assessed according to 36- Item Short Form Survey (SF-36) questionnaire filled at admission and then at 6 weeks after the surgery
单臂
探索性研究/预试验
N/A
/
nil
/
67
/
2014-03-01
2023-03-16
/
All patients presenting to the Outpatients with pilonidal sinus with or without abscess will be included in the study;
请登录查看Only failure to give consent will be excluded;
请登录查看Shifa international hospital
/
医药经济报2025-12-12
医学新视点2025-12-12
上海拓界生物医药2025-12-12
绽妍JUYOU2025-12-12
隆门资本2025-12-12
信邦制药2025-12-12
君实医学2025-12-12
触界生物2025-12-12
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12